ReviewHealthcare (Basel, Switzerland)2026
Clinical Management of Patellar Tendinopathy in Athletes: A Narrative Review of Diagnosis, Treatment, and Return to Sport.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patellar tendinopathy affects approximately 18% of athletes and up to 45% of volleyball players, representing a common cause of load-related anterior knee pain and functional limitation in jumping and landing sports. Clinical diagnosis relies primarily on history and physical examination. However, no consensus has yet been established on standardized diagnostic criteria, particularly for imaging-based assessment, and no definitive clinical practice guideline currently exists; imaging abnormalities frequently coexist with symptoms but are also common in asymptomatic athletes, and incidental findings may carry a risk of overdiagnosis and unnecessary imaging-guided management. This narrative review synthesizes the current evidence on the clinical management of patellar tendinopathy in athletes, spanning diagnosis, treatment, long-term prognosis, and return to sport; the literature was identified through structured searches of PubMed, Web of Science, and Google Scholar, with the final search conducted on 1 July 2026. Exercise therapy represents the most extensively studied conservative approach and may be considered a reasonable first-line option, although no single loading mode has demonstrated clear superiority and the underlying evidence is of low to very low certainty; injection strategies differ in mechanisms and evidence strength, but most data come from short-term studies. These studies commonly combine injections with exercise, making the injection's isolated effect unclear. Additionally, shockwave therapy is not supported by current evidence as a first-line or stand-alone option. Because structural imaging changes and clinical symptoms frequently diverge, functional outcomes rather than imaging endpoints should guide load progression and return-to-sport decisions. This review provides clinicians with a practical synthesis of the currently available evidence for treatment selection and patient management, and identifies remaining uncertainties, particularly in adolescent populations and long-term outcome prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.